Candida at Boston City Hospital. Clinical and epidemiological characteristics and susceptibility to eight antimicrobial agents.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology*; D001437:Bacteriuria / Q000382:microbiology; D001900:Boston; D002175:Candida / Q000187:drug effects*; D002177:Candidiasis / Q000453:epidemiology*; D002648:Child; D002675:Child, Preschool; D003428:Cross Infection; D005260:Female; D006760:Hospitalization; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009761:Nystatin / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D013183:Sputum / Q000382:microbiology; D014546:Urinary Catheterization; D014946:Wound Infection / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D009761:Nystatin; D000666:Amphotericin B; D012293:Rifampin